University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 17 of 23
Role of the Laser Pointer in Budgeting Fluoroscopy Time and Radiation Exposure
NCT02051582
Detecting Lung Infections Through Vibration
NCT02056860
Breath Condensate Study in Patients With Cystic Fibrosis.
NCT02056132
Nutritional PSA's on Fruit and Vegetable Consumption
NCT01948466
ACE Inhibitors Combined With Exercise for Seniors - Pilot Study
NCT01891513
The Effect of AGE on the Immune System
NCT01959646
Potato Fiber and Gastrointestinal Function: Phase 3
NCT01964599
Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure
NCT02053246
Almonds: Digestive Health and Immune Function of Adults and Children
NCT01973595
Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1
NCT01994486
Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
NCT02195999
Effect of AIDET on Physician-Patient Communication
NCT01947400
Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease
NCT01854242
Problem Specific Templates for Electronic Hospital Documentation
NCT01958723
Implementing an Emergency Department to Home Care Transition Intervention
NCT01973296
Pancreas Volume in Preclinical Type 1 Diabetes
NCT02234947
Early Initiation of Milk Expression in Mothers of Very Low Birth Weight Infants
NCT01892085
NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
NCT01954576
Aspiration of Residual Gastric Contents
NCT01863043
A Validation of a Genomics Based Prognostic in Severe Trauma
NCT01810328
Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
NCT01810458
High Resolution Manometry for Swallowing
NCT01773330
Camera Based System to Monitor Patient Movement During Radiation Treatment
NCT01971866
High Ticagrelor Loading Dose in STEMI
NCT01898442
A Multilevel Approach to Increasing HPV Vaccine Initiation Among Adolescents - Part 3
NCT04208269
Subthalamic Deep Brain Stimulation (DBS) in Parkinson's Disease
NCT02012647
The Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation
NCT01879098
Rural Lifestyle Eating and Activity Program (Rural LEAP)
NCT02054624
Pharmacogenomic Evaluation of Antihypertensive Responses in Induced Pluripotent Stem (iPS) Cells Study
NCT01943383
The Determination of Important Mechanical Patterns of Left Ventricular Efficiency-MV02 Study
NCT01807819
Dose-Response of Salmeterol in Children
NCT01907334
Safety Study of Nicardipine to Treat Cerebral Vasospasm
NCT01810302
Oxytocin's Effect on Socioemotional Aging
NCT01823146
Therapist Assisted Online Treatment for Anxiety
NCT01816204
Hypoglycemia in Prader-Willi Syndrome
NCT01897363
Longitudinal Study of Traumatic Brain Injury (TBI) in (University of Florida) UF Athletes
NCT01890304
Cardiovascular Disease Protection Tissue
NCT02348515
Walking Adaptability Post-Spinal Cord Injury
NCT01851629
Developing a Non-invasive Cardiac Functional Health Status Measurement Device
NCT01877343
Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 Diabetes
NCT01883258
Response to Diaphragmatic Pacing in Subjects With Pompe Disease
NCT02354651
Proton Radiation Therapy for Macular Degeneration
NCT01833325
Respiratory Kinematics During Voluntary and Reflex Cough in Healthy Adults
NCT01854268
Radiotherapy for Oligometastatic Prostate Cancer
NCT01859221
Effect of Aerobic Interval Training on Cardiovascular Function in Aging
NCT01883271
The Impact of a Modified Probe Tip Design on Patient Perception of Discomfort on Probing and Clinical Parameters Using the Florida Probe® System
NCT03690479
Wear of Enamel Against Polished Zirconia Crowns
NCT02289781
Cough-Generated Aerosols of NTM in Cystic Fibrosis
NCT01815866
Vitamin D as a Supplement Against Falls in Elderly Study
NCT01827345
Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma
NCT01764607
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.